Search results
1 gru 2023 · Emerging research suggests whey protein (WP) supplementation may modify type 2 diabetes mellitus (T2DM) risk factors, including glucose control.
6 mar 2023 · Milk-derived whey as well as casein proteins can produce insulin secretion in obese, pre-diabetic, and also type 2 diabetes individuals [24,25,26,27,28,29]. Studies in humans have shown that whey protein decreases postprandial glycemia and could be used in medical/nutritional therapy to regulate blood sugar [ 30 , 31 ].
10 paź 2015 · As whey protein can augment incretin hormone secretion and enhance protein-stimulated insulin release, it seems reasonable to view whey as a potential therapeutic agent in the treatment of type 2 diabetes.
1 lip 2022 · Whey protein (WP) supplementation improves glycemic control. The mechanisms of glucose lowering effect of WP in healthy subjects and patients are identical. WP can suppress appetite and slow gastric emptying as well, which leads to glycaemia control.
Protein intake before meals has been shown to reduce postprandial glycemia in type 2 diabetes (T2DM) by stimulating secretion of insulin and incretins as well as by delaying gastric emptying.3–7 Among different proteins, whey protein (WP) was found to be most efficacious probably because WP is rich in leucine and branched-chain amino acids ...
19 paź 2020 · This review discusses evidence surrounding the provision of mealtime whey protein to treat postprandial hyperglycaemia in individuals with type 2 diabetes and highlights areas to help facilitate its clinical application.
6 mar 2023 · This review discusses all the biochemical and clinical aspects of the benefits of high-quality whey, which is now considered a functional food, for prevention and improvement of T2DM and CVDs by insulin- and non-insulin-dependent mechanisms.
